Aim According to established guidelines, patients with Stage III colon cancer should receive
adjuvant chemotherapy. However, a significant proportion do not. This study assessed …

Purpose Adjuvant chemotherapy has been known as a standard treatment for patients with
resected colon cancer. However, in elderly colon cancer patients, the characteristics of …

Objectives: The benefit of adding oxaliplatin to adjuvant fluoropyrimidine chemotherapy in
patients> 70 years is controversial. This retrospective audit investigated usage, benefit and …

Background Adjuvant chemotherapy after curative resection is established as a standard
therapy for colon and rectal cancer. Although the efficacy of adjuvant chemotherapy has …

Background We determined to what extent patients with colon cancer stage III≥ 75 years
received adjuvant chemotherapy and the impact on overall and disease-specific survival …

Background Adjuvant chemotherapy is relatively underused in older patients with colon
cancer in Japan, and its age-specific effects on clinical outcomes remain unclear. This study …

Objective We aim to examine the use and outcomes of adjuvant chemotherapy in older
patients with stage II and III colon cancer. Material and Methods Using data from the SEER …

OBJECTIVES: To estimate the modifying effect of age on the survival benefit associated with
adjuvant chemotherapy receipt in elderly patients with a diagnosis of Stage III colon cancer …

Background: Adjuvant 5-fluoruracil-based chemotherapy significantly reduces mortality in
patients with stage II-III colon cancer, but is less prescribed with rising age. In this study we …

Background: Adjuvant chemotherapy has become the standard form of treatment for all
patients with stage III colorectal cancer and is also recommended for patients with stage II …